title: [Sclerosing peritonitis and practolol (author's transl)].
abstract: Skin manifestations, eye complications, a nephrotic syndrome, appearance of lupus erythematosus cells and antinuclear antibodies, sometimes combined with a systemic side effects of the beta adrenergic blocker Practolol. Another side effect is though to be sclerosing peritonitis. The latter is identical with the idiopathic fibroplastic peritonitis, described at the turn of this fibroplastic peritonitis, described at the turn of this century by German authors. Our own observation of a case of sclerosing peritonitis is compared with the literature. There is strong evidence for a causal relationship between longstanding Practolol-therapy and sclerosing peritonitis. Practolol was withdrawn from the market in 1975.
mesh_terms: D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D005260:Female; D006801:Humans; D010538:Peritonitis / Q000139:chemically induced*; D011217:Practolol / Q000008:administration & dosage / Q000009:adverse effects*; D012598:Sclerosis; D013997:Time Factors
chemical_list: D011217:Practolol
vernacular_title: Sklerosierende Peritonitis durch Practolol.